{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34321596",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41371-021-00582-9"
    ],
    "Journal": {
      "ISSN": "1476-5527",
      "JournalIssue": {
        "Volume": "35",
        "Issue": "9",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "Journal of human hypertension",
      "ISOAbbreviation": "J Hum Hypertens"
    },
    "ArticleTitle": "Is resistance training alone an antihypertensive therapy? A meta-analysis.",
    "Pagination": {
      "StartPage": "769",
      "EndPage": "775",
      "MedlinePgn": "769-775"
    },
    "Abstract": {
      "AbstractText": [
        "Evidence concerning the prescription of isolated resistance training (RT) to hypertensive individuals is limited. Guidelines are divergent concerning RT inclusion for prehypertensive and hypertensive persons. A meta-analysis investigating data with larger sample sizes provides more robust effect size estimates and allows for inferences on clinical choices concerning the effectiveness of RT alone. In this context, the aim of this meta-analysis was to assess the effects of RT alone on the systolic (SBP) and diastolic (DBP) blood pressures in prehypertensive and hypertensive individuals. Data from 13 studies involving 417 participants (207 assigned to RT and 210 controls) were obtained. The results indicate significant reductions in SBP (-6.16\u2009mmHg CI -8.27 to -4.04; I<sup>2</sup>: 31.0% P value for heterogeneity\u2009=\u20090.136 and effect size\u2009=\u2009-0.59) and DBP (-3.70\u2009mmHg CI -5.19 to -2.21; I<sup>2</sup>: 18.3% P value for heterogeneity\u2009=\u20090.106 and effect size\u2009=\u2009-0.55) when compared to control groups. In conclusion, RT alone is able to reduce SBP and DBP in prehypertensive and hypertensive subjects, especially in elderly individuals."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Nature Limited."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-3750-2517"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal do Par\u00e1-UFPA, P\u00f3s-Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular, Bel\u00e9m, PA, Brazil. odilonsalim@hotmail.com."
          }
        ],
        "LastName": "Abrahin",
        "ForeName": "Odilon",
        "Initials": "O"
      },
      {
        "Identifier": [
          "0000-0001-8017-012X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de S\u00e3o Paulo-UNIFESP, Laborat\u00f3rio de Imunologia Pulmonar e do Exerc\u00edcio, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "Moraes-Ferreira",
        "ForeName": "Renilson",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0001-8824-8075"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade do Estado do Par\u00e1-UEPA, Laborat\u00f3rio de Bioqu\u00edmica do Exerc\u00edcio, Bel\u00e9m, PA, Brazil."
          }
        ],
        "LastName": "Cortinhas-Alves",
        "ForeName": "Erik Artur",
        "Initials": "EA"
      },
      {
        "Identifier": [
          "0000-0003-1979-3656"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal do Par\u00e1-UFPA, P\u00f3s-Gradua\u00e7\u00e3o em Gen\u00e9tica e Biologia Molecular, Bel\u00e9m, PA, Brazil."
          }
        ],
        "LastName": "Guerreiro",
        "ForeName": "Jo\u00e3o Farias",
        "Initials": "JF"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Meta-Analysis",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Hum Hypertens",
    "NlmUniqueID": "8811625",
    "ISSNLinking": "0950-9240"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antihypertensive Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Hum Hypertens. 2021 Aug 5;:",
      "PMID": "34354254"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antihypertensive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Blood Pressure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Hypertension"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Resistance Training"
    }
  ]
}